Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis

Purpose: To determine the safety and outcome profile of five-fraction stereotactic radiotherapy (FSRT) for brain metastases (BM), either as a definitive or adjuvant treatment. Methods: We assessed clinical data of patients receiving five fractions of 7 Gy each (cumulative physical dose of 35 Gy) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Layer, Julian P., Layer, Katharina, Sarria, Gustavo R., Röhner, Fred, Dejonckheere, Cas S., Friker, Lea L., Zeyen, Thomas, Koch, David, Scafa, Davide, Leitzen, Christina, Köksal, Mümtaz, Schmeel, Frederic Carsten, Schäfer, Niklas, Landsberg, Jennifer, Hölzel, Michael, Herrlinger, Ulrich, Schneider, Matthias, Giordano, Frank A., Schmeel, Leonard Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955428/
https://www.ncbi.nlm.nih.gov/pubmed/36826062
http://dx.doi.org/10.3390/curroncol30020101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955428/
https://www.ncbi.nlm.nih.gov/pubmed/36826062
http://dx.doi.org/10.3390/curroncol30020101

Ejemplares similares